Atlas Trials

The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.

Clinical trial NCT02032095 · COMPLETED

Trial details

NCT number
NCT02032095
Sponsor
Japan Blood Products Organization
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2013-11-01
Primary completion
2015-09-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.